Table 3

- Comparing telepharmacy and standard clinic follow-up for warfarin-naive patients.

Variables	Univariable			Multivariable
Variables	OR	95% CI	P-value	aOR	95% CI	P-value
Age (years)	0.988	0.971 to 1.006	0.192	0.989	0.969 to 1.009	0.286
Male versus female	1.934	1.062 to 3.523	0.031	1.792	0.951 to 3.376	0.071
Weight	1.015	0.998 to 1.032	0.081	1.015	0.997 to 1.034	0.109
BMI	1.023	0.977 to 1.071	0.34
Diabetes	0.65	0.342 to 1.238	0.19	0.73	0.353 to 1.506	0.394
Hypertension	0.842	0.459 to 1.542	0.577
CKD	0.648	0.166 to 2.526	0.532
Target INR
2 to 3	reference
2.5 to 3.5	0.567	0.111 to 2.89	0.495
TELE versus on-Site	0.63	0.34 to 1.165	0.14	0.58	0.301 to 1.115	0.102
antithromboticsb	0.855	0.415 to 1.76	0.67
NSAIDS c	0.747	0.187 to 2.986	0.68

b: includes aspirin or clopidogrel c: includes Ibuprofen, Lornixicam, Celecoxib, CKD: chronic kidney disease, INR: International normalized ratio, NSAIDS: non-steroidal anti-inflammatory drugs, TELE: telepharmacy, CI: confidence interval, aOR: adjusted odds ratio